EXTH-54. METFORMIN ACTS SYNERGISTICALLY WITH GALLIUM MALTOLATE TO INHIBIT THE PROLIFERATION OF GLIOBLASTOMA CELLS BY ACTION ON MITOCHONDRIAL FUNCTION

Por Alhajala, Hisham S, Al-Gizawiy, Mona M, Schmainda, Kathleen M, Chitambar, Christopher R
Publicado no Neuro Oncol (2017)

HGG-14. IRRADIATION OF PEDIATRIC GLIOBLASTOMA CELLS INDUCES DOWNREGULATION OF TUMOR SUPPRESSOR MICRORNA GENES AND UPREGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)

Por Alhajala, Hisham, Doan, Ninh, Al-Gizawiy, Mona, Knipstein, Jeffrey, Schmainda, Kathleen, Chitambar, Cristopher
Publicado no Neuro Oncol (2018)

EXTH-48. ORAL GALLIUM MALTOLATE IMPAIRS TUMOR GROWTH AND EXTENDS DISEASE-SPECIFIC SURVIVAL IN A XENOGRAFT MODEL OF RECURRENT GBM

Por Al-Gizawiy, Mona, Robert, Wujek, Alhajala, Hisham, Cobb, Jonathan, Prah, Melissa, Mirza, Shama, Chitambar, Christopher, Schmainda, Kathleen
Publicado no Neuro Oncol (2018)

EXTH-40. TUMOR IRON STATUS SENSITIZES GLIOBLASTOMA CELLS TO THE CYTOTOXICITY OF AN INHIBITOR OF THE IRON-DEPENDENT M2 SUBUNIT OF RIBONUCLEOTIDE REDUCTASE

Por Alhajala, Hisham S, Joshi, Devashish, Al-Gizawiy, Mona M, Hedlund, Bo, Elford, Howard L, Schmainda, Kathleen M, Chitambar, Christopher R
Publicado no Neuro Oncol (2017)

TMOD-09. A PATIENT-DERIVED XENOGRAFT MODEL MIMICKING RECURRENT PEDIATRIC MALIGNANT GLIOMA

Por Al-Gizawiy, Mona M., Doan, Ninh B., Wujek, Robert T., Alhajala, Hisham S., Mirza, Shama P., Chitambar, Christopher R., Schmainda, Kathleen M.
Publicado no Neuro Oncol (2017)

THER-12. NOVEL IRON-TARGETED THERAPY IS HIGHLY EFFECTIVE IN TREATMENT-RESISTANT HIGH-GRADE GLIOMA IN VIVO

Por Al-Gizawiy, Mona, Wujek, Robert, Prah, Melissa, Knipstein, Jeffrey, Alhajala, Hisham, Doan, Ninh, Molino, Salvatore, Mirza, Shama, Chitambar, Christopher, Schmainda, Kathleen
Publicado no Neuro Oncol (2019)

TMOD-08. IN VITRO PRE-TREATMENT OF CELL LINES PRODUCES A ROBUST IN VIVO XENOGRAFT MODEL MIMICKING RECURRENT GLIOBLASTOMA

Por Al-Gizawiy, Mona M, Wujek, Robert T, Alhajala, Hisham S, Doan, Ninh B, Knipstein, Jeffrey, Connelly, Jennifer M, Mirza, Shama P, Chitambar, Christopher R, Schmainda, Kathleen M
Publicado no Neuro Oncol (2017)

Gallium Maltolate Disrupts Tumor Iron Metabolism and Retards the Growth of Glioblastoma by Inhibiting Mitochondrial Function and Ribonucleotide Reductase

Por Chitambar, Christopher R., Al-Gizawiy, Mona M., Alhajala, Hisham S., Pechman, Kimberly R., Wereley, Janine P., Wujek, Robert, Clark, Paul A., Kuo, John S., Antholine, William E., Schmainda, Kathleen M.
Publicado no Mol Cancer Ther (2018)

Identification of radiation responsive genes and transcriptome profiling via complete RNA sequencing in a stable radioresistant U87 glioblastoma model

Por Doan, Ninh B., Nguyen, Ha S., Alhajala, Hisham S., Jaber, Basem, Al-Gizawiy, Mona M., Ahn, Eun-Young Erin, Mueller, Wade M., Chitambar, Christopher R., Mirza, Shama P., Schmainda, Kathleen M.
Publicado no Oncotarget (2018)

Irradiation of pediatric glioblastoma cells promotes radioresistance and enhances glioma malignancy via genome-wide transcriptome changes

Por Alhajala, Hisham S., Nguyen, Ha S., Shabani, Saman, Best, Benjamin, Kaushal, Mayank, Al-Gizawiy, Mona M., Erin Ahn, Eun-Young, Knipstein, Jeffery A., Mirza, Shama, Schmainda, Kathleen M., Chitambar, Christopher R., Doan, Ninh B.
Publicado no Oncotarget (2018)

Acid ceramidase and its inhibitors: a de novo drug target and a new class of drugs for killing glioblastoma cancer stem cells with high efficiency

Por Doan, Ninh B., Alhajala, Hisham, Al-Gizawiy, Mona M., Mueller, Wade M., Rand, Scott D., Connelly, Jennifer M., Cochran, Elizabeth J., Chitambar, Christopher R., Clark, Paul, Kuo, John, Schmainda, Kathleen M., Mirza, Shama P.
Publicado no Oncotarget (2017)